Works by Xue, Zhu


Results: 637
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Dorzagliatin (HMS5552), a novel dual‐acting glucokinase activator, improves glycaemic control and pancreatic β‐cell function in patients with type 2 diabetes: A 28‐day treatment study using biomarker‐guided patient selection.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2113, doi. 10.1111/dom.13338
    By:
    • Zhu, Xiao‐Xue;
    • Zhu, Da‐Long;
    • Li, Xiao‐Ying;
    • Li, Ya‐Lin;
    • Jin, Xiao‐Wei;
    • Hu, Tian‐Xin;
    • Zhao, Yu;
    • Li, Yong‐Guo;
    • Zhao, Gui‐Yu;
    • Ren, Shuang;
    • Zhang, Yi;
    • Ding, Yan‐Hua;
    • Chen, Li
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50